Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Treatment of HBV related cirrhosis.

van Bömmel F, Berg T.

Liver Int. 2013 Feb;33 Suppl 1:176-81. doi: 10.1111/liv.12074. Review.

PMID:
23286862
2.

Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.

Al-Hamoudi W, Elsiesy H, Bendahmash A, Al-Masri N, Ali S, Allam N, Al Sofayan M, Al Bahili H, Al Sebayel M, Broering D, Saab S, Abaalkhail F.

World J Gastroenterol. 2015 Jul 14;21(26):8140-7. doi: 10.3748/wjg.v21.i26.8140.

3.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators.

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

4.

Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.

Stock PG, Fung J.

Liver Transpl. 2009 Sep;15(9):1003-6. doi: 10.1002/lt.21840. No abstract available.

5.

Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis.

Das K, Das K, Datta S, Pal S, Hembram JR, Dhali GK, Santra A, Chowdhury A.

Liver Int. 2010 Aug;30(7):1033-42. doi: 10.1111/j.1478-3231.2010.02255.x. Epub 2010 May 14.

PMID:
20492502
6.

Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.

Cholongitas E, Papatheodoridis GV.

World J Gastroenterol. 2013 Dec 28;19(48):9189-97. doi: 10.3748/wjg.v19.i48.9189. Review.

7.

Management of patients with decompensated HBV cirrhosis.

Fontana RJ.

Semin Liver Dis. 2003 Feb;23(1):89-100. Review.

PMID:
12616454
8.

Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.

Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.

J Gastroenterol Hepatol. 2011 Nov;26(11):1638-45. doi: 10.1111/j.1440-1746.2011.06777.x.

PMID:
22011297
9.

Hepatitis B viral load affects prognosis of hepatocellular carcinoma.

Yu SJ, Kim YJ.

World J Gastroenterol. 2014 Sep 14;20(34):12039-44. doi: 10.3748/wjg.v20.i34.12039. Review.

10.

Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.

Kim CH, Um SH, Seo YS, Jung JY, Kim JD, Yim HJ, Keum B, Kim YS, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS.

J Gastroenterol Hepatol. 2012 Oct;27(10):1589-95. doi: 10.1111/j.1440-1746.2012.07167.x.

PMID:
22554121
11.

Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.

Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL-HBV) Study Group.

Gastroenterology. 2010 May;138(5):1747-54. doi: 10.1053/j.gastro.2010.01.042. Epub 2010 Jan 28.

PMID:
20114048
12.

Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.

Burra P, De Martin E.

Transplant Proc. 2011 Jul-Aug;43(6):2455-6. doi: 10.1016/j.transproceed.2011.06.017. Review.

PMID:
21839292
13.

Chronic viral hepatitis and hepatocellular carcinoma.

Barazani Y, Hiatt JR, Tong MJ, Busuttil RW.

World J Surg. 2007 Jun;31(6):1243-8.

PMID:
17440771
14.

Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.

Huang L, Li J, Lau WY, Yan J, Zhou F, Liu C, Zhang X, Shen J, Wu M, Yan Y.

J Gastroenterol Hepatol. 2012 Jan;27(1):158-64. doi: 10.1111/j.1440-1746.2011.06888.x.

PMID:
21871026
15.

Hepatitis B virus-related cirrhosis: natural history and treatment.

Chu CM, Liaw YF.

Semin Liver Dis. 2006 May;26(2):142-52. Review.

PMID:
16673292
16.

A score model for predicting post-liver transplantation survival in HBV cirrhosis-related hepatocellular carcinoma recipients: a single center 5-year experience.

Wang LY, Zheng SS, Xu X, Wang WL, Wu J, Zhang M, Shen Y, Yan S, Xie HY, Chen XH, Jiang TA, Chen F.

Hepatobiliary Pancreat Dis Int. 2015 Feb;14(1):43-9.

PMID:
25655289
17.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

18.

Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.

Saab S, Hunt DR, Stone MA, McClune A, Tong MJ.

Liver Transpl. 2010 Jun;16(6):748-59. doi: 10.1002/lt.22072.

19.

Hepatitis B virus infection and liver transplantation.

Kennedy M, Alexopoulos SP.

Curr Opin Organ Transplant. 2010 Jun;15(3):310-5. doi: 10.1097/MOT.0b013e32833991f8. Review.

PMID:
20445447
20.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903

Supplemental Content

Support Center